AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Nov 19 2021
News
FDA authorizes Pfizer-BioNTech and Moderna COVID-19 boosters for all adults
The Food and Drug Administration on Friday approved COVID-19 booster shots from Pfizer-BioNTech and Moderna for all adults, opening a new chapter in the vaccine rollout and allowing the Biden administration to catch up to states that advised residents to seek an extra dose regardless of eligibility.
Senior regulators said they want to act quickly to backfill waning immunity and
Washington Times
Jul 27 2020
News
Moderna Funding Nears $1 Billion as Vaccine Study Starts
Moderna Inc. climbed as much as 11% Monday after getting a second round of U.S. funding for an experimental vaccine for COVID-19 and kicking off its late-stage trial.
With an additional $472 million award from the Biomedical Advanced Research and Development Authority (BARDA) announced on Sunday, Moderna’s shot is now backed by $955 million of funds from the U.S.
The first
Newsmax (News)
May 25 2021
News
Moderna's Covid-19 vaccine appears safe and powerfully effective in teens
Moderna said Tuesday that its Covid-19 vaccine provided strong protection in teens ages 12 to 17 in a late-stage trial.
The finding could pave the way for the shot to become the second authorized in the U.S. for use in teens, after the Food and Drug Administration expanded authorization of Pfizer's shot to include kids ages 12 to 15.
The company said in a press release that the
Politico
May 06 2021
News
Moderna says its COVID-19 vaccine is 96% effective in teens
Moderna's COVID-19 vaccine is 96% effective in teenagers 12- to 17-years-old, the drugmaker said Thursday. The company announced results of the Phase 2 trial in reporting first-quarter earnings. Its vaccine generated $1.7 billion in revenue in its fiscal first quarter.
Evidence that Moderna's vaccine is effective in teens comes as rival Pfizer is expected to receive federal
CBS News (Online)
May 06 2021
News
Moderna says its COVID-19 vaccine is 96% effective in teens
Moderna's COVID-19 vaccine is 96% effective in teenagers 12- to 17-years-old, the drugmaker said Thursday. The company announced results of the Phase 2 trial in reporting first-quarter earnings. Its vaccine generated $1.7 billion in revenue in its fiscal first quarter.
Evidence that Moderna's vaccine is effective in teens comes as rival Pfizer is expected to receive federal
CBS News (Online)
May 06 2021
News
Moderna says COVID-19 vaccine 96 percent effective in teens
Moderna on Thursday released the results of its COVID-19 vaccine trials for those aged 12 to 17, reporting it 96 percent effective against the virus.
The vaccine manufacturer said its trial, involving 3,235 participants, recorded 12 COVID-19 cases that emerged beginning 14 days after the first dose. The company said it had not identified any serious safety concerns to date.
The
The Hill
Jun 20 2022
News
White House COVID adviser touts Moderna, Pfizer shots as ‘good choices’ for parents of kids under 5
White House COVID-19 response coordinator Ashish Jha on Monday heralded the recent authorization of COVID-19 vaccines for kids under the age of 5, saying it gives parents “two good choices.”
Last week, the Food and Drug Administration (FDA) authorized Moderna’s and Pfizer’s COVID-19 vaccines for children under age 5, the last group of people in the U.S. to be permitted to receive
The Hill
Oct 21 2021
News
CDC advisers set to vote on Moderna, J&J boosters, mixing and matching doses
An independent Centers for Disease Control and Prevention advisory committee on Thursday is set to discuss and vote on booster shots for the Moderna and Johnson & Johnson COVID-19 vaccines, along with the potential for people to mix and match their booster doses.
On Wednesday, the FDA authorized Moderna and J&J boosters for some, and allowed for mix and matching booster doses
ABC News (Online)
Oct 22 2021
News
Moderna and Johnson & Johnson COVID-19 vaccine booster shots greenlighted by CDC
The Centers for Disease Control and Prevention formally recommended booster shots for many recipients of Moderna and Johnson & Johnson's COVID-19 vaccines on Thursday. As a result, up to 99 million Americans are now eligible for additional doses.
Providers expect to administer the first booster shots for the newly eligible Americans as early as tomorrow.
"These
CBS News (Online)
Oct 14 2021
News
FDA vaccine advisers are meeting to consider Moderna Covid-19 vaccine boosters
Vaccine advisers to the US Food and Drug Administration are meeting Thursday to discuss whether to authorize boosters of Moderna's coronavirus vaccine for some adults.
It's the first portion of a two-day Vaccines and Related Biological Products Advisory Committee meeting that will also include a vote on boosters for the Johnson & Johnson vaccine and a presentation on mix-and-match
CNN (Online News)